Vogenx Inc. (VOGX) Gamma Exposure (GEX) & Greeks

Gamma exposure (GEX) analysis shows how options positioning creates dealer hedging pressure across strikes. Includes delta, vanna, charm, vomma, and vega exposure by strike price.

Vogenx Inc. (VOGX) operates in the Healthcare sector, specifically the Biotechnology industry, listed on NASDAQ, employing roughly 4 people, carrying a beta of 0.00 to the broader market. Vogenx is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia (PBH) and gastroparesis. public since 2026-08-12.

Greeks exposure analysis shows dealer hedging pressure across strike prices for all six Greeks. No recent options activity for VOGX as of 2026-08-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how gamma exposure is reported and how to read the data →